Brussels Airport is accelerating preparations for the COVID-19 vaccine

Still many unknown parameters, every scenario mapped out

Brussels Airport is ready to receive and ship the first COVID-19 vaccines. A taskforce at Brucargo, the cargo division of the airport, is working full force on preparing scenarios for the import and export of the various types of vaccines in a safe and efficient way.

“As Europe’s preferred airport for the transport of temperature-sensitive products, Brussels Airport has been investing for over 10 years in a range of services and products tailored to the needs of the pharmaceutical sector, one of the country’s key industries. We have, together with our community partner Air Cargo Belgium, set up the Taskforce BRUcure specially for the COVID-19 vaccine so that we can guarantee, in partnership with the major vaccine manufacturers, a reliable and rapid transport at our airport”, says Arnaud Feist, CEO of Brussels Airport Company.

Brussels Airport not only has the largest number of pharma-certified companies under the IATA CEIV1 programme on the cargo site. With 30,000m² of temperature-controlled areas, it also has the largest number of m² in Europa in first and second-line access to the tarmac to provide refrigerated storage of pharmaceutical products

With its digital data-sharing platform BRUcloud, Brussels Airport wants to make it possible to track temperature-sensitive shipment in real time and monitor temperatures at any moment in the transport chain.

The Taskforce BRUcure is mapping out all scenarios for the various types of vaccines in close consultation with the pharmaceutical companies with which Brussels Airport works. Each type of vaccine demands a different form of transport, packaging and storage. Some vaccines, for example, have to be shipped on dry ice, while others will demand refrigeration at the customary 2-8 degrees Celsius.

In addition, the manufacturing location of the vaccines, the number of doses per person, the volume that a cargo pallet with vaccines will occupy taking into account the packaging, and so on, are mapped out in different scenarios, in order to quickly respond once a vaccine is available.

Geert Keirens of Air Cargo Belgium: “The COVID-19 vaccine story yet again shows the strength of Brucargo. Thanks to the community’s extensive experience in transporting vaccines, in particular the Ebola vaccine on dry ice, and the long-standing collaboration, our cargo community can offer a robust logistics platform for importing and exporting all types of COVID-19 vaccines, at the service of public health. In addition, ACB, thanks to a partnership with the province of Flemish Brabant, is focusing on a community control tower function, whereby COVID-19 vaccine shipments will be continuously monitored at Brucargo.”

1 https://www.iata.org/en/programs/cargo/pharma/ceiv-pharma/

Share

Latest stories

Website preview
Website preview
Memorandum of Understanding signed to boost pharma supply chain between Brussels Airport and the United States
On 20 April, Brussels Airport signed a memorandum of understanding (MoU) with United Airlines and the Virginia Economic Development Partnership (VEDP), the state authority responsible for stimulating and supporting the development and expansion of Virginia's economy. The MoU aims to set up a dedicated pharmaceutical corridor between Brussels Airport and Washington Dulles International Airport, creating aligned processes and a standardised flow between both airports. This partnership confirms Brussels Airport’s leading role as Europe’s preferred pharma hub and further strengthens its position as a trusted partner in building efficient and reliable pharma supply chains between Europe and the rest of the world.
pressroom.brusselsairport.be
Website preview

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About Brussels Airport

Brussels Airport is one of the most important airports in Europe. In 2025, Brussels Airport welcomed 24.4 million passengers and transported 795,000 tonnes of cargo through the airport. Brussels Airport caters for the specific needs of business travellers and holidaymakers alike, on both intra-European and long haul flights. In 2026, the airport offers direct connections between Belgium and 205 destinations worldwide, with flights operated by 83 airlines.   

The airport also offers a leading cargo platform, specialised in the transport of pharmaceutical products, perishable goods, e-commerce and live animals. Brussels Airport is the most important pharmaceutical hub in Europe.

With its SHIFT 2027 strategy Brussels Airport Company intends to strengthen its position as a major European hub, accelerate its ambitious sustainability goals, e.g. through the European Green Deal project Stargate, and continue to diversify its activities by focusing on innovation and cooperation.

Brussels Airport is the second most important economic engine in Belgium, good for 64,000 direct and indirect jobs and is owned and operated by Brussels Airport Company. The shareholders are a consortium between PMV and private investors (75%) and FPIM/SFPI (25%). 

Follow Brussels Airport on TwitterLinkedinInstagramTikTok and Facebook.  

Contact

Press Office Brussels Airport Company Luchthaven Brussel Nationaal 1M 1930 Zaventem

+32 (0)2 753 53 53 (for journalists only)

media@brusselsairport.be

www.brusselsairport.be